Clinical significance of RANTES and MIP-1 alpha in acute rejection episode in kidney transplantation / 中国医学科学院学报
Acta Academiae Medicinae Sinicae
;
(6): 70-72, 2004.
Artigo
em Chinês
| WPRIM
| ID: wpr-231985
ABSTRACT
<p><b>OBJECTIVE</b>To discuss the correlation between acute rejection episodes and expression of regulated upon activation normal T cell expressed and secreted (RANTES) and macrophage inflammatory protein-1 alpha (MIP-1 alpha) gene following kidney transplantation.</p><p><b>METHODS</b>A total of 76 kidney biopsies (episode biopsy) were performed on both 57 patients with allograft dysfunction following transplantation and 19 patients without rejection, and the latter were served as controls. All acute rejections were confirmed by histological examination. The expressions of RANTES and MIP-1 alpha mRNA in all samples were assayed by reverse transcription polymerase chain reaction.</p><p><b>RESULTS</b>Thirty-eight (66.7%) of 57 cases with acute rejection had strong expression of RANTES, and 41 (72%) had expression of MIP-1 alpha. Only four (21%) of 19 controls had mild expression of RANTES, and 5 (26%) had expression of MIP-1 alpha, which evoked a statistical significance (P < 0.001) when compared with those with acute rejections.</p><p><b>CONCLUSIONS</b>The expressions of chemokines RANTES and MIP-1 alpha are important in the process of immune reaction in the rejection of transplanted kidney, which may imply a potential way for early diagnosis and treatment of acute rejection after further research.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Biópsia
/
Biomarcadores
/
Doença Aguda
/
Transplante de Rim
/
Quimiocina CCL5
/
Proteínas Inflamatórias de Macrófagos
/
Reação em Cadeia da Polimerase Via Transcriptase Reversa
/
Quimiocina CCL4
/
Genética
Tipo de estudo:
Estudo de rastreamento
Limite:
Adolescente
/
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Acta Academiae Medicinae Sinicae
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS